Variant
VHL M3I(c.3G>A) and M211L (c.631A>C)
CI-VAR-00002591Explore in graph →CIViC 3720
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 31034483
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Von Hippel-Lindau Disease1unmapped disease | ||||||||
| VHL M3I(c.3G>A) and M211L (c.631A>C) | (predisposing) | Predisposing | C | N/A N/A | 3 | submitted | EID10130Out of 48 Danish families presenting with renal cell carcinoma, one patient was found to harbor the germline mutations c.3G>A (p.Met1Ile) and c.631A>C (p.Met211Leu) in the VHL gene. This patient was d… (full text at CIViC) PMID 31034483 · Christensen et al., 2019 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available
No ClinVar interpretation attached to this variant.